Universidad de los Andes Medical School, Carrera 7 # 116-05, Of. 413, Bogotá, Colombia.
Department of Internal Medicine, Fundación Santa Fe de Bogotá, Section of Endocrinology, Carrera 7 No. 117 - 15, Bogotá, Colombia.
Lipids Health Dis. 2020 May 25;19(1):106. doi: 10.1186/s12944-020-01291-x.
The functionality of high-density lipoproteins (HDL) is a better cardiovascular risk predictor than HDL concentrations. One of the key elements of HDL functionality is its apolipoprotein composition. Lecithin-cholesterol acyl transferase (LCAT) and cholesterol-ester transfer protein (CETP) are enzymes involved in HDL-mediated reverse cholesterol transport. This study assessed the concentration and activity of LCAT and CETP in HDL subspecies defined by their content of apolipoproteins E (apoE) and C-III (apoC-III) in humans.
Eighteen adults (ten women and eight men, mean age 55.6, BMI 26.9 Kg/m, HbA1c 5.4%) were studied. HDL from each participant were isolated and divided into four subspecies containing respectively: No apoE and no apoC-III (E-C-), apoE but not apoC-III (E + C-), apoC-III but no apoE (E-C+) and both apoE and apoC-III (E + C+). The concentration and enzymatic activity of LCAT and CETP were measured within each HDL subspecies using immunoenzymatic and fluorometric methods. Additionally, the size distribution of HDL in each apolipoprotein-defined fraction was determined using non-denaturing electrophoresis and anti-apoA-I western blotting.
HDL without apoE or apoC-III was the predominant HDL subtype. The size distribution of HDL was very similar in all the four apolipoprotein-defined subtypes. LCAT was most abundant in E-C- HDL (3.58 mg/mL, 59.6% of plasma LCAT mass), while HDL with apoE or apoC-III had much less LCAT (19.8, 12.2 and 8.37% of plasma LCAT respectively for E + C-, E-C+ and E + C+). LCAT mass was lower in E + C- HDL relative to E-C- HDL, but LCAT activity was similar in both fractions, signaling a greater activity-to-mass ratio associated with the presence of apoE. Both CETP mass and CETP activity showed only slight variations across HDL subspecies. There was an inverse correlation between plasma LCAT activity and concentrations of both E-C+ pre-beta HDL (r = - 0.55, P = 0.017) and E-C- alpha 1 HDL (r = - 0.49, P = 0.041). Conversely, there was a direct correlation between plasma CETP activity and concentrations of E-C+ alpha 1 HDL (r = 0.52, P = 0.025).
The presence of apoE in small HDL is correlated with increased LCAT activity and esterification of plasma cholesterol. These results favor an interpretation that LCAT and apoE interact to enhance anti-atherogenic pathways of HDL.
高密度脂蛋白(HDL)的功能比其浓度更能预测心血管风险。HDL 功能的一个关键要素是其载脂蛋白组成。卵磷脂胆固醇酰基转移酶(LCAT)和胆固醇酯转移蛋白(CETP)是参与 HDL 介导的胆固醇逆转运的酶。本研究评估了 LCAT 和 CETP 在人类 HDL 亚种中的浓度和活性,这些亚种是根据载脂蛋白 E(apoE)和 C-III(apoC-III)的含量来定义的。
研究了 18 名成年人(10 名女性和 8 名男性,平均年龄 55.6,BMI 26.9 Kg/m,HbA1c 5.4%)。从每位参与者中分离出 HDL,并根据其载脂蛋白 E(apoE)和 C-III(apoC-III)的含量分为四个亚种:既没有 apoE 也没有 apoC-III(E-C-)、只有 apoE 但没有 apoC-III(E+C-)、只有 apoC-III 但没有 apoE(E-C+)和既有 apoE 也有 apoC-III(E+C+)。使用免疫酶和荧光方法在每个 HDL 亚种内测量 LCAT 和 CETP 的浓度和酶活性。此外,使用非变性电泳和抗 apoA-I 免疫印迹法测定每个载脂蛋白定义亚类中 HDL 的大小分布。
没有 apoE 或 apoC-III 的 HDL 是主要的 HDL 亚型。所有四个载脂蛋白定义的亚种中 HDL 的大小分布非常相似。LCAT 在 E-C- HDL 中最为丰富(3.58mg/mL,占血浆 LCAT 质量的 59.6%),而含有 apoE 或 apoC-III 的 HDL 中 LCAT 含量较少(分别为血浆 LCAT 的 19.8%、12.2%和 8.37%,E+C-、E-C+和 E+C+)。E+C- HDL 中的 LCAT 质量低于 E-C- HDL,但 LCAT 活性相似,表明与 apoE 存在相关的活性与质量比更大。CETP 质量和 CETP 活性在 HDL 亚种之间仅略有变化。血浆 LCAT 活性与 E-C+前-β HDL(r=-0.55,P=0.017)和 E-C-α1 HDL(r=-0.49,P=0.041)的浓度呈负相关。相反,血浆 CETP 活性与 E-C+α1 HDL 的浓度呈正相关(r=0.52,P=0.025)。
apoE 在小 HDL 中的存在与 LCAT 活性增加和血浆胆固醇酯化有关。这些结果表明,LCAT 和 apoE 相互作用增强了 HDL 的抗动脉粥样硬化途径。